Surviving sepsis - : Practice guidelines, marketing campaigns, and Eli LillyEICHACKER, Peter Q; NATANSON, Charles; DANNER, Robert L et al.The New England journal of medicine. 2006, Vol 355, Num 16, pp 1640-1642, issn 0028-4793, 3 p.Article

Lethal and edema toxins in the pathogenesis of Bacillus anthracis septic shock : Implications for therapySHERER, Kevin; YAN LI; XIZHONG CUI et al.American journal of respiratory and critical care medicine. 2007, Vol 175, Num 3, pp 211-221, issn 1073-449X, 11 p.Article

Antitumor Necrosis Factor Therapy Is Associated With Improved Survival in Clinical Sepsis Trials: A Meta-AnalysisPING QIU; XIZHONG CUI; JUNFENG SUN et al.Critical care medicine. 2013, Vol 41, Num 10, pp 2419-2429, issn 0090-3493, 11 p.Article

Practice Misalignments in Randomized Controlled Trials: Identification, Impact, and Potential SolutionsDEANS, Katherine J; MINNECI, Peter C; DANNER, Robert L et al.Anesthesia and analgesia. 2010, Vol 111, Num 2, pp 444-450, issn 0003-2999, 7 p.Article

Drotrecogin alfa (activated) (recombinant human activated protein C) for the treatment of severe sepsis. Pro and conBERNARD, Gordon R; EICHACKER, Peter Q; NATANSON, Charles et al.Critical care medicine. 2003, Vol 31, Num 1, pp S85-S96, issn 0090-3493, SUPArticle

An overview of anthrax infection including the recently identified form of disease in injection drug usersHICKS, Caitlin W; SWEENEY, Daniel A; XIZHONG CUI et al.Intensive care medicine (Print). 2012, Vol 38, Num 7, pp 1092-1104, issn 0342-4642, 13 p.Article

Anthrax InfectionSWEENEY, Daniel A; HICKS, Caitlin W; XIZHONG CUI et al.American journal of respiratory and critical care medicine. 2011, Vol 184, Num 12, pp 1333-1341, issn 1073-449X, 9 p.Article

Novel therapies for sepsis : A reviewDEANS, Katherine J; HALEY, Michael; NATANSON, Charles et al.The Journal of trauma, injury, infection, and critical care. 2005, Vol 58, Num 4, pp 867-874, issn 1079-6061, 8 p.Article

Meta-analysis of acute lung injury and acute respiratory distress syndrome trials testing low tidal volumesEICHACKER, Peter Q; GERSTENBERGER, Eric P; BANKS, Steven M et al.American journal of respiratory and critical care medicine. 2002, Vol 166, Num 11, pp 1510-1514, issn 1073-449X, 5 p.Article

Meta-analysis: The effect of steroids on survival and shock during sepsis depends on the doseMINNECI, Peter C; DEANS, Katherine J; BANKS, Steven M et al.Annals of internal medicine. 2004, Vol 141, Num 1, pp 47-56, issn 0003-4819, 10 p.Article

Sublethal doses of Bacillus anthracis lethal toxin inhibit inflammation with lipopolysaccharide and Escherichia coli challenge but have opposite effects on survivalXIZHONG CUI; VAN LI; XUEMEI LI et al.The Journal of infectious diseases. 2006, Vol 193, Num 6, pp 829-840, issn 0022-1899, 12 p.Article

The individual survival benefits of tumor necrosis factor soluble receptor and fluid administration are not additive in a rat sepsis modelPING QIU; YAN LI; YI DING et al.Intensive care medicine (Print). 2011, Vol 37, Num 10, pp 1688-1695, issn 0342-4642, 8 p.Article

Ethyl pyruvate decreased early nuclear factor-κB levels but worsened survival in lipopolysaccharide-challenged miceJUNWU SU; XUEMEI LI; XIZHONG CUI et al.Critical care medicine. 2008, Vol 36, Num 4, pp 1059-1067, issn 0090-3493, 9 p.Article

DTPA Fe(III) decreases cytokines and hypotension but worsens survival with Escherichia coli sepsis in ratsYAN LI; XUEMEI LI; HALEY, Michael et al.Intensive care medicine (Print). 2006, Vol 32, Num 8, pp 1263-1270, issn 0342-4642, 8 p.Article

Effective dosing of lipid a analogue E5564 in rats depends on the timing of treatment and the route of Escherichia coli infectionSOLOMON, Steven B; XIZHONG CUI; GERSTENBERGER, Eric et al.The Journal of infectious diseases. 2006, Vol 193, Num 5, pp 634-644, issn 0022-1899, 11 p.Article

Recombinant human activated protein C in sepsis: Assessing its clinical useHALEY, Michael; XIZHONG CUI; MINNECI, Peter C et al.The American journal of the medical sciences. 2004, Vol 328, Num 4, pp 215-219, issn 0002-9629, 5 p.Article

The importance of usual care control groups for safety monitoring and validity during critical care researchMINNECI, Peter C; EICHACKER, Peter Q; DANNER, Robert L et al.Intensive care medicine (Print). 2008, Vol 34, Num 5, pp 942-947, issn 0342-4642, 6 p.Article

Anthrax Lethal and Edema Toxins Produce Different Patterns of Cardiovascular and Renal Dysfunction and Synergistically Decrease Survival in CaninesSWEENEY, Daniel A; XIZHONG CUI; SOLOMON, Steven B et al.The Journal of infectious diseases. 2010, Vol 202, Num 12, pp 1885-1896, issn 0022-1899, 12 p.Article

Bacillus anthracis edema and lethal toxin have different hemodynamic effects but function together to worsen shock and outcome in a rat model. CommentaryARTENSTEIN, Andrew W; XIZHONG CUI; SHERER, Kevin et al.The Journal of infectious diseases. 2007, Vol 195, Num 4, issn 0022-1899, 471-473,572-580 [12 p.]Article

Fluid support worsens outcome and negates the benefit of protective antigen-directed monoclonal antibody in a lethal toxin-infused rat bacillus anthracis shock modelSHERER, Kevin; YAN LI; EICHACKER, Peter Q et al.Critical care medicine. 2007, Vol 35, Num 6, pp 1560-1567, issn 0090-3493, 8 p.Article

Lethality during continuous anthrax lethal toxin infusion is associated with circulatory shock but not inflammatory cytokine or nitric oxide release in ratsXIZHONG CUI; MOAYERI, Mahtab; YAN LI et al.American journal of physiology. Regulatory, integrative and comparative physiology. 2004, Vol 55, Num 4, pp R699-R709, issn 0363-6119Article

Sympathetic blockade in a canine model of gram-negative bacterial peritonitisSOLOMON, Steven B; BANKS, Steven M; GERSTENBERGER, Eric et al.Shock (Augusta, Ga.). 2003, Vol 19, Num 3, pp 215-222, issn 1073-2322, 8 p.Article

Bacillus anthracis Cell Wall Peptidoglycan but Not Lethal or Edema Toxins Produces Changes Consistent With Disseminated Intravascular Coagulation in a Rat ModelPING QIU; YAN LI; FITZ, Yvonne et al.The Journal of infectious diseases. 2013, Vol 208, Num 6, pp 978-989, issn 0022-1899, 12 p.Article

Protective Antigen Antibody Augments Hemodynamic Support in Anthrax Lethal Toxin Shock in CaninesBAROCHIA, Amisha V; XIZHONG CUI; JUNFENG SUN et al.The Journal of infectious diseases. 2012, Vol 205, Num 5, pp 818-829, issn 0022-1899, 12 p.Article

Bacillus anthracis cell wall produces injurious inflammation but paradoxically decreases the lethality of anthrax lethal toxin in a rat modelXIZHONG CUI; JUNWU SU; BESCH, Virginia et al.Intensive care medicine. Supplement. 2010, Vol 36, Num 1, pp 148-156, issn 0935-1701, 9 p.Article